menu search

Bitcoin primed to explode by over 400%, says crypto analyst

The analyst predicted over a 400% increase in Bitcoin’s value. The timeline for this significant Bitc...

November 4, 2023, 5:29 pm

Gold price at resistance under $2,000 ahead of the us nfp

The US and Canadian data should move the rate today. Its failure to retest the broken uptrend line sign...

November 4, 2023, 4:59 pm

Gbp/usd price analysis: pound holds steady after boe’s pause

The pound showed resilience following the Bank of England’s decision to hold rates. The BoE signaled ...

November 4, 2023, 4:59 pm

Dollar dives on risk appetite revival and sliding yields

In a week marked by a significant shift in investor sentiment, Dollar found itself at the bottom of the...

November 4, 2023, 2:38 pm

Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc

The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy de...

November 4, 2023, 12:00 pm

Gold ira vs traditional ira: what’s the difference?

backed by physical gold, can protect your investment against inflation and changes in currency value. While its contributions aren’t tax-deductible,...

November 4, 2023, 11:44 am

Gold prices forecast: xau/usd gains on us dollar’s pain

Amidst a softer dollar and tempered U.S. Treasury yields, spot gold’s surge signals investor caution ...

November 4, 2023, 10:38 am

Biden's ai executive order: it's about understanding this technology, the risks, says c3.ai ceo

President Biden signed into action a sweeping executive order to promote innovation in artificial intel...

November 4, 2023, 9:00 am

Palantir q3 earnings: focus on government contracts (rating upgrade)

Palantir Technologies reported strong Q3 2023 earnings, indicating significant upside potential for inv...

November 4, 2023, 7:28 am

Gold prices forecast: xau/usd gains on us dollar's pain

Amidst a softer dollar and tempered U.S. Treasury yields, spot gold's surge signals investor caution in...

November 4, 2023, 6:38 am

This dividend growth stock has a problem the market is missing right now

Fastenal's third-quarter earnings led to a 7.5% stock price advance on the day of the release. While Wall Street was clearly pleased with the industri...

November 4, 2023, 6:06 am

Wall street thinks this ultra-high-yield dividend stock down nearly 30% this year is a screaming buy

Devon Energy's share price has fallen significantly in 2023 due to lower oil and gas prices and economi...

November 4, 2023, 5:51 am

Bitcoin price remains below $35,000 as new crypto cloud mining project presale hits $3 million mark

Bitcoin price have struggled to attract buyers above $35,000, while the Bitcoin Minetrix presale has gained si...

November 4, 2023, 5:44 am

These 2 artificial intelligence (ai) stocks have a lot to prove before i'm willing to buy

Investors have bid AI stocks significantly higher this year. C3.ai's shares have surged, but growth has...

November 4, 2023, 5:01 am

Federal signal corporation (fss) q3 2023 earnings call transcript

Federal signal Corporation (NYSE:FSS ) Q3 2023 Earnings Conference Call November 2, 2023 10:00 AM ET Co...

November 4, 2023, 1:49 am

Canadian imports softening on lower consumer and business spending

The week ahead will be a lighter one for data releases after signs of decelerating Canadian GDP growth,...

November 4, 2023, 12:31 am

Seacor marine: good company, but not good enough

The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...

November 4, 2023, 12:05 am

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance

In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...

November 3, 2023, 8:30 pm

Citigroup: can jane fraser save citi?

The inability to correct underlying issues identified in multiple consent orders going back years has caused s...

November 3, 2023, 7:45 pm


Search within

Pages Search Results: